Much excitement was hyped in the late 1990s when a new class of arthritis drugs, known as the highly selective COX-2 inhibitors, was manufactured in the late 1990s. The drugs were considered a superior option promising to effectively relieve pain in conditions such as arthritis without stomach side
|
